Bausch + Lomb Receives FDA Approval for enVista® Envy™ Full Range of Vision Intraocular Lens
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has ...
Le Lézard17h
Bausch + Lomb Receives FDA Approval for enVista® Envytm Full Range of Vision Intraocular Lens
Bausch + Lomb Corporation , a leading global eye health company dedicated to helping people see better to live better, today announced that the U.S. Food and Drug Administration has approved the ...
ophthalmologytimes15h
FDA approves Bausch + Lomb’s enVista Envy range of IOLs
According to the company, enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks ...
Asia One3h
CooperVision to Host 4th Asia-Pacific Myopia Management Symposium in Seoul, South Korea
Held in partnership with the Korean Association of Paediatric Ophthalmology and Strabismus (KAPOS), the event will focus on advancing paediatric myopia management and shaping the future of eye health ...
ophthalmologytimes8h
Anthony Wallace of Bausch + Lomb talks about enVista Envy FDA approval
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
Cetera Investment Advisers Raises Stake in The Cooper Companies, Inc. (NASDAQ:COO)
Cetera Investment Advisers boosted its holdings in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 6.3% during the second quarter, according to the company in its most recent disclosure with ...